PostNL NV (PNL)
Euronext Amsterdam · Netherlands · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 0.801 |
|---|---|
| 52-week range | 0.801 – 1.280 |
| Return, 1 month / 3 months | −7.0% / −12.6% |
| Return, 1 year / 3 years | −15.6% / −49.4% |
| Trend | Below its 200-day average |
| RSI (14) | 29 |
| Volatility (1 year) | 26.2% |
| Worst drawdown (1 year) | -34.0% |
| Average daily value traded | 1.86M EUR |
| Dividend yield | 5.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PostNL is a postal and logistics company based in the Netherlands. It collects, sorts and delivers letters, cards and parcels for households and business customers, mainly in the Netherlands, and it also runs parcel delivery operations in Belgium and Germany. Its services include mail delivery, parcel shipping for online shops and consumers, and international mail and logistics. The company operates a network of sorting centres, delivery rounds and staffed and unstaffed retail points where customers can send and collect items.
PostNL NV trades under the code PNL on the Euronext Amsterdam in Netherlands, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PostNL NV (PNL) trades on the Euronext Amsterdam in Netherlands. It last closed at EUR 0.801 on 22 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 77 of 109 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.6% and over the last three months it fell 12.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Amsterdam
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.1% | ||
| From 52-week high | -36.4% | ||
| Momentum | 22 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.6% | ||
| 6-month return | -25.1% | ||
| 12-month return, skipping the last month | -9.3% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.0% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.86M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.7% |
|---|---|
| 1 month | −7.0% |
| 3 months | −12.6% |
| 6 months | −25.1% |
| 1 year | −15.6% |
| 3 years | −49.4% |
| 5 years | −71.3% |
Signals
| 50-day / 200-day average | 0.864 / 0.977 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.016 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Apr 2026 | EUR 0.0400 |
| 17 Apr 2025 | EUR 0.0400 |
| 7 Aug 2024 | EUR 0.0300 |
| 18 Apr 2024 | EUR 0.0300 |
| 9 Aug 2023 | EUR 0.0600 |
| 20 Apr 2023 | EUR 0.0200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Amsterdam; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.